Loading the latest PSX data…
Loading the latest PSX data…
IBL HealthCare LimitedShariah-compliant
+0.49 (+1.20%) today
Market closed, last update Nov 17, 2026 11:37 PMThe IBL HealthCare share price was Rs 41.41 (+1.20%) at the last PSX update (Nov 17, 2026 11:37 PM). IBLHL is a pharmaceuticals stock with a market value of Rs 4.1bn.
Last session's range17 Nov 2026
40.4068% up the range41.89
52-week range
36.0011% up the range85.82
Price limits (circuit breakers)
36.8356% up the range45.01
IBLHL ranks better than 16% of the 311 liquid PSX stocks we score. Each factor is a 0-100 rank (value is ranked half within pharmaceuticals). Education only, not a buy or sell signal.
−10.5% over 6M(KSE-100 +5.5%)
Daily bars from PSX's end-of-day market summary. Prices before a bonus issue, right issue or split are adjusted so the chart stays continuous; cash dividends are not taken out.
Full-screen IBLHL chart with levelsDownload IBLHL price history (CSV)Compare IBLHL with GLAXO
From daily closes to 2026-11-17. A description of the trend, not a forecast.
Trend reading
Mixed
Down2 up · 4 down signalsUp
| S2 | S1 | Pivot | R1 | R2 |
|---|---|---|---|---|
| 39.74 | 40.58 | 41.23 | 42.07 | 42.72 |
| Announced | Period | Payout | Profit after tax | EPS (Rs) | Books close |
|---|---|---|---|---|---|
| 29 Oct 11:00 | 1st quarter to 30 Sept | None | Rs 64.1m | 0.65 | – |
| 23 Sept 15:46 | Full year to 30 Jun | None | Rs 220.4m | 2.24 | 19 Oct – 27 Oct |
| 30 Apr 10:51 | 9 months to 31 Mar | None | Rs 167.5m | 1.70 | – |
| Measure | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Sales growth | +6.6% | +20.0% | −10.5% | – |
| Profit growth | +5.8% | +2,658.1% | −97.6% | – |
| EPS growth | +6.2% | +2,244.4% | −97.5% | – |
| Net margin | 4.8% | 4.8% | 0.2% | 7.7% |
| Measure | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Sales growth | +0.0% | – | – | – |
| Profit growth | −8.1% | – | – | – |
| EPS growth | −8.5% | – | – | – |
| Net margin | 5.7% | 5.1% | 3.7% | 6.2% |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Sales | Rs 4.6bn | Rs 4.3bn | Rs 3.6bn | Rs 4.0bn |
| Profit after tax | Rs 220m | Rs 208m | Rs 8m | Rs 309m |
| Earnings per share (Rs) | 2.24 | 2.11 | 0.09 | 3.61 |
| Line item | Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|
| Sales | Rs 1.1bn | Rs 1.2bn | Rs 971m | Rs 1.1bn |
| Profit after tax | Rs 64m | Rs 62m | Rs 36m | Rs 70m |
| Earnings per share (Rs) | 0.65 | 0.63 | 0.36 | 0.71 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross margin | 35.7% | 33.5% | 26.4% | 33.3% |
| Net margin | 4.8% | 4.8% | 0.2% | 7.7% |
| EPS growth | 6.2% | 2,244.4% | -97.5% | -14.9% |
| PEG | 3.84 | 0.01 | -3.52 | -0.61 |
Rupee amounts from PSX filings (thousands converted to Rs m/bn). Data by Capital Stake via the PSX Data Portal; standardised, so it can differ from the annual report. Latest quarter (Q1 2027) EPS fell 8.5% from the same quarter a year earlier.
| Measure | IBLHL | Sector median | Reading |
|---|---|---|---|
| P/E | 19.0 | 12.1 | Dearer than peers |
| Dividend yield | – | 5.1% | – |
| Net margin | 4.8% | 9.4% | Below peers |
| EPS growth | +6.2% | +34.5% | Below peers |
| 1-year return | −24.9% | −12.6% | Below peers |
Sector P/E check. At the sector's median P/E of 12.1, last year's EPS of Rs 2.24 would price IBLHL at about Rs 27.13 (−34% from today). A rough yardstick only: sectors hold very different businesses, and the market prices future profits, not last year's.
Estimate a fair value for IBLHL (Graham, Lynch, DCF)IBLHL pivot levels
Ratios as published on the PSX Data Portal (standardised by Capital Stake), latest financial year on the right.
Work out your IBLHL dividend income after tax
PSX quotes payouts as a percentage of face value; cash per share assumes the usual Rs 10 face value. You get the dividend if you own the shares before the books close.
Market value
16th of 18
Rs 4.1bn
P/E (cheapest first)
11th of 13
19.0
1-year return
14th of 15
-24.9%
EPS growth
12th of 15
6.2%
Net margin
13th of 16
4.8%
danioPSX score
12th of 13
16/100
| GLAXOGlaxoSmithKline Pakistan Limited | Rs 106.1bn | −1.89% | 9.7 | 6.1% | −15.4% | 87 |
| ABOTAbbott Laboratories (Pakistan) Limited | Rs 98.5bn | +0.18% | 10.6 | 4.4% | −7.6% | 81 |
| HALEONHaleon Pakistan Limited | Rs 79.8bn | −1.15% | 12.2 | 3.6% | −16.6% | 67 |
| HINOONHighnoon Laboratories Limited | Rs 51.1bn | +0.89% | 12.4 | 5.4% | −14.3% | 78 |
| SEARLThe Searle Company Limited | Rs 46.6bn | −0.37% | 12.0 | – | −23.6% | 53 |
| AGPAGP Limited | Rs 43.2bn | −0.84% | 24.1 | 5.1% | −18.3% | 49 |
| HPLHoechst Pakistan Limited | Rs 38.8bn | +0.53% | 11.1 | 6.9% | −2.7% | – |
| FEROZFerozsons Laboratories Limited | Rs 15.7bn | −0.96% | 22.8 | 1.6% | −9.0% | 39 |
| CPHLCiti Pharma Ltd. | Rs 14.4bn | −0.74% | 17.7 | – | −23.2% | 31 |
| GSKCHGlaxoSmithKline Consumer Healthcare | Rs 14.1bn | −3.13% | – | – | – | – |
| BFBIOBF Biosciences Limited | Rs 12.0bn | −0.60% | 18.2 | – | −10.8% | 45 |
| MACTERMacter International Limited | Rs 11.7bn | −1.08% | 3.7 | – | −27.9% | 52 |
| SAPLSanofi-Aventis Pakistan Limited | Rs 8.4bn | 0.00% | – | – | – | – |
| OTSUOtsuka Pakistan Limited | Rs 5.7bn | +0.79% | 11.6 | – | +39.6% | 65 |
| LIVENLiven Pharma Limited | Rs 5.4bn | +10.00% | – | – | −2.3% | 15 |
Swipe the table sideways for more columns.
No director or substantial-shareholder trades in IBLHL read from PSX notices yet.
Read automatically (OCR) from the disclosure images companies file with PSX under Regulation 5.6.1(d). A digit can be misread, so check the original notice before relying on a figure. Value = shares × price. Not investment advice. All PSX insider trades
IBL HealthCare Limited was incorporated in Pakistan under the repealed Companies Ordinance, 1984 (now the Companies Act, 2017) as a private limited company on July 14, 1997. In November 2008, the Company was converted into public limited company. The principal activities of the Company include marketing, selling and distribution of healthcare products.
Where the price sits in its 52-week range
Low 36.0011% of the way upHigh 85.82
Data: PSX Data Portal (Nov 17, 2026 11:37 PM); company data refreshed 17 Nov; daily bars from PSX market summaries; five-year record from danioPSX research. Logos are trademarks of their owners. Not a recommendation to buy or sell IBLHL. Official PSX page for IBLHL